# Dauch (DCH): A Value Writer Stays Long as Preliminary Q3 and a November 6 Print Test the Synergy Case > Dauch Corporation (NYSE: DCH), the American Axle and Dowlais combination, prints full third-quarter results on November 6, 2026. Value writer Colin King of Value Don't Lie (@valuedontlie) has called Dauch his favorite asymmetric special situation and pushed back on a steep BofA cut. Preliminary figures already show Adj. EBITDA of $355 million to $360 million and a tighter full-year Adj. EBITDA range. We check the synergy math against the debt load. By MCAFax · Published November 5, 2026 Section: Markets & Main Street › From Wall Street · Series: Market Calls, Investigated (https://mcafax.com/notebook/series/market-calls-investigated) Canonical: https://mcafax.com/notebook/dch-dauch-synergy-case-into-november-6-earnings Source: MCAFax, The Broker's Notebook (https://mcafax.com/notebook). MCAFax is not a lender or a law firm. --- Dauch Corporation (NYSE: DCH) reports full third-quarter results on November 6, 2026. Value writer Colin King (@valuedontlie) has stayed long through a BofA downgrade and a soft tape, calling Dauch his favorite asymmetric special situation. Preliminary company figures already sketch Adj. EBITDA of $355 million to $360 million and a narrower full-year band. We check whether the $300 million synergy plan still clears the debt. *This is journalism and commentary, not investment advice. We hold no position unless stated.* ## Key facts - **Ticker and exchange:** Dauch Corporation, DCH, NYSE (also London). - **Situation type:** Post-merger special situation in a levered auto supplier. - **The call:** Colin King is long DCH; October 24, 2026 he rebutted a BofA cut by pointing to about $300 million of guided cost synergies. - **Price:** DCH closed at $4.63 on October 23, 2026 (last close before that post) and about $4.53 on November 5, 2026. - **Preliminary Q3 (company 8-K, October 30, 2026):** Net loss $42 million to $47 million; Adjusted EBITDA $355 million to $360 million. - **FY26 guide update:** Sales $10.8 billion to $10.875 billion; Adjusted EBITDA cut to $1.350 billion to $1.375 billion from $1.360 billion to $1.425 billion. - **Synergies (Q2 update):** About $70 million run-rate versus a more-than-$100 million year-one goal and $300 million by end of year three. - **Full print:** Conference call 10:00 a.m. ET November 6, 2026. ## What changed into the print? King's October 16 reply to the BofA Underperform/$5 target cut was blunt: he was long and called the cut steep. His October 24 [follow-up](https://x.com/valuedontlie/status/2113982087699071008) said the downgrade looked Q3-focused and pointed to $300 million of guided cost synergies from the February 2026 merger - about $1.25 a share pre-tax on a then ~$4.60 stock by his framing. Dauch's October 30 [Form 8-K](https://www.dauch.com/investor-sec/external/0001062231/19890670/pdf) then previewed Q3 Adj. EBITDA of $355 million to $360 million and cut the full-year Adj. EBITDA range to $1.350 billion to $1.375 billion, citing customer production volatility, inflation and energy costs. Sales guidance moved up slightly on metal pass-throughs. That is the tape King's synergy long has to clear on November 6. ## Who's making this call and why? Colin King writes Value Don't Lie on spin-offs, stubs and special situations. On our [scoreboard](https://mcafax.com/notebook/market-calls-scoreboard) he is 11-8 (.579) on 19 scored career calls, average edge about +35.1 points, median +4.2, last 10 at 4-6. His Dauch path: February 2026 Quick Value piece with a $5 low / $10 high framing; July 24 "favorite asymmetric special situation"; October pushback on BofA. The stock has drifted near the low end of that February band. **Other supporters:** - **Alex Roepers (Atlantic Investment Management)** discussed Dauch as a deep-value special situation on a June 2026 Yet Another Value Podcast episode (episode notes disclose a long). - **The Value Pond (@TheValuePond)** after Q2 said Dauch was showing a glimpse of the business once Dowlais is integrated. - **TD Cowen** had a Buy/$10 target in September per secondary reports we flagged in an earlier draft; confirm against the firm's own note. ## Who disagrees? - **BofA Securities:** Underperform with a $5 target in mid-October, citing softer Ram heavy-duty production and estimated Q3 EBITDA pressure. - **Company guide:** Full-year Adj. EBITDA ceiling cut by $50 million at the high end. - **Balance-sheet bears:** Net leverage still elevated after the Dowlais deal; almost all enterprise value is debt if equity stays near $1.1 billion. ## What are the key facts to verify on November 6? - Final Q3 Adj. EBITDA versus the $355 million to $360 million preview. - Synergy run-rate versus the more-than-$100 million year-end goal ($70 million as of the Q2 update). - Net leverage and adjusted free cash flow versus prior ranges. - Any change to the $300 million year-three synergy target. ## What would prove it right or wrong? Signals the long case is working: - Synergies re-accelerate toward the year-one goal and free cash flow funds deleveraging. - FY26 Adj. EBITDA holds the new band without another cut. Signals it is failing: - Another guide cut, synergy slippage, or free cash flow after restructuring staying near zero into 2027. *This is journalism and commentary, not investment advice. We hold no position unless stated.* ## Questions readers ask **Is Dauch (DCH) stock a good bet into the November 6 earnings print?** It depends on whether synergy delivery and free cash flow can shrink a large debt load. DCH closed at $4.63 on October 23, 2026 before Colin King's October 24 note and about $4.53 on November 5, 2026. Preliminary Q3 Adj. EBITDA is $355 million to $360 million. **What did Colin King say most recently?** On October 24, 2026 he argued a BofA downgrade looked Q3-focused and pointed to about $300 million of guided cost synergies from the February 2026 American Axle/Dowlais merger, roughly $1.25 a share pre-tax on a ~$4.60 stock in his framing. **What are the preliminary Q3 figures?** Dauch's October 30, 2026 Form 8-K previewed a Q3 net loss of $42 million to $47 million and Adjusted EBITDA of $355 million to $360 million. Full results and a call are set for November 6, 2026 at 10:00 a.m. ET. **How did full-year guidance change?** Sales guidance rose to $10.8 billion to $10.875 billion. Adjusted EBITDA was cut to $1.350 billion to $1.375 billion from $1.360 billion to $1.425 billion on macro headwinds. **Where do synergies stand?** As of the Q2 update Dauch cited about $70 million of run-rate savings versus a more-than-$100 million year-one target, $180 million by end of year two and $300 million by end of year three. **Who is Colin King?** He writes the Value Don't Lie newsletter on special situations. In our tracking he is 11-8 on 19 scored calls at 180 days versus the S&P 500, average edge about +35.1 points. **Who else is constructive?** Alex Roepers discussed Dauch on a June 2026 podcast (long disclosed in episode notes). The Value Pond was constructive after Q2 on integration progress. **Who disagrees?** BofA cut Dauch to Underperform with a $5 target in mid-October on softer Ram heavy-duty production. The company's own FY Adj. EBITDA ceiling also came down in the October 30 preview. **What would show the thesis failed?** Another guide cut, synergy run-rate stuck near $70 million into year-end, or free cash flow after restructuring near zero into 2027. **Does this piece recommend buying or selling DCH?** No. This is journalism about a publicly posted long thesis and company-reported preliminary figures. It is not a buy or sell recommendation.